Abstract
Parkinson’s disease (PD) is a dopaminergic-related pathology in which basal ganglia functioning are altered. It has been postulated that a direct receptor-receptor – i.e. dopamine D2 receptor (D2R) and adenosine A2A receptor (A2AR) – interaction may be finely regulating this brain area. Accordingly, elucidating whether the pathology prompts changes on these structures could grant valuable information for the design of new PD therapies. Here, we first resolved a long-standing question concerning D2R-A2AR assembly in native tissue. Thus, by means of different complementary experimental approaches (i.e. immunoelectron microscopy, proximity ligation assay and TR-FRET), we unambiguously identified native D2R/A2AR oligomers in rat striatum. Subsequently, we determined that under pathological conditions (i.e. in a rat PD model) D2R-A2AR interaction was impaired. Collectively, these results provide definitive evidence for a native D2R/A2AR oligomer alteration in experimental parkinsonism, thus conferring the rationale for appropriate oligomer-based PD treatments.
- Received September 4, 2014.
- Accepted November 10, 2014.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed.
Article navigation
Related articles
Cited by...
More in this TOC section
Similar articles
Other journals from The Company of Biologists
Featured resource: A classification system for zebrafish adipose tissues
A new Resource article from James Minchin and John Rawls presents a standardized nomenclature and classification system for zebrafish adipose tissues, and regression models to predict expected adipose size during the course of zebrafish development.
Why should you publish your next paper in Disease Models & Mechanisms?
From single-celled organisms to patient-derived models, cancer to neurodegeneration, Disease Models & Mechanisms publishes the best original research and resources that focus on the use of model systems to better understand, diagnose and treat human disease. Submit your paper here.
Editor's choice: a powerful new model for neuropsychiatric disorders
A new Drosophila model to study the role of schizophrenia-associated gene PRODH in behavioural disorders has been developed by a team lead by Patrick Callaerts from the University of Leuven in Belgium. Their Research article describes how this model reveals that precise regulation of proline metabolism in the lateral neurons ventral region of the brain is crucial for maintaining normal behaviour patterns. Read a press release on the discovery here.
Focus on lysosomal storage diseases
In the latest issue, we present two new articles focused on lysosomal storage diseases (LSDs). A Research article from Michael Hoch and co-authors presents a detailed analysis of lipid accumulation, lysosomal dysfunction and neurodegeneration in a Drosophila sphingolipidosis model, while Ellen Sidransky et al. discuss how iPSCs provide new opportunities to explore the biology and pathophysiology of LSDs in a new Review.
Transfer to Biology Open
If your submission to Disease Models & Mechanisms is unsuccessful, did you know you can transfer your paper and any reviews directly to our sister journal, Biology Open? The majority of papers transferred with reviews are accepted for publication. Find out how here.